CCA
GMED icon

Criterion Capital Advisors’s Globus Medical GMED Stock Holding History

Criterion Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$8.77K Hold
128
– – 0.01% 263
2024
Q3 		$8.77K Hold
128
– – 0.01% 263
2024
Q2 		$8.77K Hold
128
– – 0.01% 263
2024
Q1 		$6.87K Buy
+128
New +$6.88K ﹤0.01% 278

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Criterion Capital Advisors's GMED Position: Q4 2024 in Review

Criterion Capital Advisors held its Globus Medical (GMED) position steady in Q4 2024 at 128 shares worth $8.77K. The position accounts for 0.01% of the portfolio, ranked #263.

Criterion Capital Advisors first reported a position in GMED in Q1 2024 and has held it in 4 quarters since. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

  • Criterion Capital Advisors held 128 shares of Globus Medical worth $8.77K as of Q4 2024.
  • Criterion Capital Advisors left its Globus Medical share count unchanged in Q4 2024.
  • Globus Medical made up 0.01% of Criterion Capital Advisors's portfolio in Q4 2024, its #263 holding.
  • Criterion Capital Advisors first reported a position in Globus Medical in Q1 2024 and has held it in 4 quarters since.
  • 500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.